Patent · US Active

SIRP-gamma polypeptide compositions and treatment of cancer

US11407801B2 · kind B2 · utility

1Cited by

1References

6Claims

0Family size

Assignee

Ab Initio Biotherapeutics, Inc. · US

Inventors

Aaron Michael Ring · New Haven, US
Roy Louis Maute · San Francisco, US
Andrew Kruse · Brookline, US
Aashish Manglik · Menlo Park, US
Kenneth Lin · Rancho Santa Margarita, US

Key dates

Filing date	May 4, 2020
Grant date	Aug 9, 2022
Priority date	—
Expiry date	Oct 2, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/50
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are SIRP-gamma, SIRP-beta or SIRP-beta2 decoy polypeptides for immunotherapy and/or treatment of cancer, anemia, transplant, asthma, allergy, auto-immune disease, and viral infection.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.